Nouf Al hemmadi
Tweet
Could combination therapy from get go, work?!
Joan Merrill @RheumNow #Rnl2022 https://t.co/m1Mt78J4RX
All News
Dr. Rachel Tate
Tweet
Dr. Joan Merrill reviews Lupus Nephritis at #RNL2022 @RheumNow https://t.co/bFiRp9xxTs
Nouf Al hemmadi
Tweet
Lupus podocytopathy.
Minimal change disease in lupus patient, no immune complex deposit.
Joan Merrill @RheumNow #Rnl2022 https://t.co/Ao2XEEMdb5
Robert B Chao, MD
Tweet
Dr. Joan Merrill on Lupus Nephritis
Developing field of urinary markers for LN but not quite ready for primetime
@RheumNow #RNL2022 https://t.co/IrUiD3eJOP
Nouf Al hemmadi
Tweet
Lupus nephritis classes:
Do not forget to Look for ⬇️
▶️Crescent and tubulointerstitial findings are a poor prognosis.
▶️Microangiopathic changes (afferent and efferent arteriole) +- role of anti coagulation.
Joan Merrill @RheumNow #Rnl2022 https://t.co/06bjobCtZZ
Dr. Rachel Tate
Tweet
Lupus podocytopathy: emerging nonimmune complex mediated nephropathy. Consider in nephrotic syndrome pts w/ normal/FSGS renal bx. Can mimic minimal change. Approx. 1% of LN bx. May benefit from cyclosporine (podocyte stabilizer) & immunosuppression. Dr. Merrill #RNL2022 @RheumNow
Dr. John Cush
Tweet
Dr. Joan Merrill on lupus at #RNL.. new Bx class lupus podocytopathy. May respond to immunosuppression and cyclosporine (podocyte stabilizer)
Elena MyasoedovaMD
Tweet
Difficult to treat #RA. Some great pearls from @RheumNow with wit and humor #RNL2022 https://t.co/XMlmPzaFK0
Elena MyasoedovaMD
Tweet
Excellent presentation on DMARD adherence by @Dr_K
👉🏻Adherence is better if meds are taken in the morning
👉🏻Communication about medication use is the key: at initial visits and follow-up #RNL2022 https://t.co/xP2qwah3kq
Dr. Rachel Tate
Tweet
Can you name the musician rheumatologist in the center of this picture? Hints: He lives in Ireland. He plays the piano. He jokes that he "had a lot more hair back then!" #RNL2022 @RheumNow
If you guessed @RonanTKavanagh then you are right! https://t.co/5YxKezJbp7
Dr. Rachel Tate
Tweet
"Top athletes and singers have coaches, should you?" Dr. Maurice Barry is a lifelong mentor of @RonanTKavanagh. #RNL2022 @RheumNow I owe my mentor, @KDAO2011, a phone call! 😉
madan
Tweet
Myeloid synovial signature predicts response to TNF inhibitors @rheumnow #RNL2022 https://t.co/YeOObzARRN
Robert B Chao, MD
Tweet
Dr. Ronan Kavanagh - Music of Rheumatology
Be like Miles Davis - create space.
Make time for pauses. It allows the patient and doctor to reflect.
@RheumNow #RNL2022 https://t.co/DlHRDdOVP1
Dr Gurdeep Dulay
Tweet
Excellent summary graphic:
Comorbidity and treatment choice in Rheumatology
Thanks to @RheumNow https://t.co/5mQed6FTJH
Janet Pope
Tweet
#ClinicalPearl #RNL Dr Joan Merrill highlights that Rx in #lupus nephritis is like the elephant 🐘 in the room - many don’t have a complete renal response & a stab in the dark after or up front with #MMF @RheumNow https://t.co/Z4ZtMNCY9y
Nouf Al hemmadi
Tweet
Lupus nephritis treatment ACR guideline.
Only 50% of patients in ALMS trail reached the primary end point. We need to do better!
Joan Merrill @RheumNow #Rnl2022 https://t.co/9TnqS8V8cB
Dr. John Cush
Tweet
Pod 2 will focus on Systemic Lupus Erythematosus. Join Dr. Joan Merrill at her presentation on Lupus Nephritis: The Blind Men and the Kidney. #RNL2022 https://t.co/yivPKWCyeX
Dr. John Cush
Tweet
Rheumatoid Faculty Panel Q&A with Drs. Cush, Choy and Michaud. #RNL2022 https://t.co/mMUoh2AaIw
Nouf Al hemmadi
Tweet
Insightful talk about Precision medicine in rheumatology by Ernest Choy.
Complex pathology = different response to treatment
▶️ Genetics.
▶️Epigenetic.
▶️Synovium biosy pathology.
▶️Seropositivity.
▶️B cell presence or absence .
@RheumNow #Rnl2022
▶️ https://t.co/7HNCnujucy
Jonathan Hausmann MD
Tweet
Super cool slide of medications to use/not to use for patients with RA and a variety of comorbidities. #RNL2022 @RheumNow #Rheumatoid #rheumatoidarthritis https://t.co/Dxm7cXG8Z5
